Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures - Pharmaceutical Technology

Patents, Intellectual Property News

Pfizer has set its FY2026 profit forecast below analyst estimates, blaming projected losses on waning Covid vaccine sales and the looming patent cliff ...